Magnetic e-Resonance Therapy, patented by Wave Neuroscience, is the combination of Transcranial Magnetic Stimulation (TMS, FDA cleared class 2 medical device/therapy), Quantitative Electroencephalogram (qEEG), and Electrocardiogram (ECG/EKG) technology to analyze and calculate treatment protocols that are tailored for each individual’s unique brain pattern.

Most other TMS treatments deliver stimulation to one area of the brain at a fixed frequency for all patients. MeRT is highly individualized to the frequency and location unique to each patient.

Clicking on the below links will take you to external sites.

Transcranial magnetic stimulation for the treatment of major depression


Major depression is often difficult to diagnose accurately. Even when the diagnosis is properly made, standard treatment approaches (eg, psychotherapy, medications, or their combination) are often inadequate to control acute symptoms or maintain initial benefit. Additional obstacles involve safety and tolerability problems, which frequently preclude an adequate course of treatment. This leaves an important gap in our ability to properly manage major depression in a substantial proportion of patients, leaving them vulnerable to ensuing complications (eg, employment-related disability, increased risk of suicide, comorbid medical disorders, and substance abuse). Thus, there is a need for more effective and better tolerated approaches. Transcranial magnetic stimulation is a neuromodulation technique increasingly used to partly fill this therapeutic void. In the context of treating depression, we critically review the development of transcranial magnetic stimulation, focusing on the results of controlled and pragmatic trials for depression, which consider its efficacy, safety, and tolerability.

Read the full article here.

Janicak, Philip G, and Mehmet E Dokucu. “Transcranial magnetic stimulation for the treatment of major depression.” Neuropsychiatric disease and treatment vol. 11 1549-60. 26 Jun. 2015, doi:10.2147/NDT.S67477

Broken Brain with Dhru Purohit, Episode 79

November 7, 2019